NASDAQ:XTLB

Xtl Biopharmaceuticals Stock Forecast

etoro logo Buy XTLB
*Your capital is at risk
$2.91
+0.0200 (+0.692%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of XTLB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XTLB to Watchlist?
Some Reasons Why To Add XTLB:
  • Lower volatility than the market (beta 0.55)
  • +21.4% YTD performance
  • Established player in the Healthcare sector
PDF

Big movements in XTL Biopharmaceuticals Ltd. stock price on Friday moving 11.07% between high and low
(Updated on Jul 10, 2026)

Buy or Hold candidate since Jul 02, 2026 Gain 7.78%

The XTL Biopharmaceuticals Ltd. stock price gained 0.692% on the last trading day (Friday, 10th Jul 2026), rising from $2.89 to $2.91. During the last trading day the stock fluctuated 11.07% from a day low at $2.62 to a day high of $2.91. The price has fallen in 5 of the last 10 days but is still up by 13.23% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 10 thousand more shares were traded than the day before. In total, 16 thousand shares were bought and sold for approximately $45.74 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.27% during the next 3 months and, with a 90% probability hold a price between $1.95 and $3.67 at the end of this 3-month period.

XTLB Signals & Forecast

The XTL Biopharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.86 and $2.51. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). XTL Biopharmaceuticals Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -7.32%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.73 and $2.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, XTL Biopharmaceuticals Ltd. finds support just below today's level at $2.73. If this is broken, then the next support from accumulated volume will be at $2.61 and $2.49.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 11.07%. For the last week, the stock has had daily average volatility of 13.76%.

Our recommended stop-loss: $2.74 (-5.84%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (XTLB) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect XTL Biopharmaceuticals Ltd. to open at $2.81, and during the day (based on 14 day Average True Range), to move between $2.75 and $3.07, which gives a possible trading interval of +/-$0.314 (+/-11.41%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 11.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.73 (6.19%) than the resistance at $3.14 (7.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is XTL Biopharmaceuticals Ltd. stock A Buy?

XTL Biopharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.315 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $2.81 ( 3.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XTLB Performance

Trading levels for XTLB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.10 6.64%
R2 2.99 2.84%
R1 2.92 0.485%
Price 2.91
S1 2.70 -7.13%
S2 2.63 -9.48%
S3 2.52 -13.29%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.56 22.34%
R2 3.25 11.68%
R1 3.14 7.90%
Price 2.91
S1 2.73 -6.19%
S2 2.61 -10.31%
S3 2.49 -14.43%

FAQ

What is the symbol for XTL Biopharmaceuticals Ltd. Stock and on which exchange is it traded?
The symbol for XTL Biopharmaceuticals Ltd. is XTLB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell XTL Biopharmaceuticals Ltd. Stock?
XTL Biopharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy XTL Biopharmaceuticals Ltd. Stock?
XTL Biopharmaceuticals Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.

What's the current price of XTL Biopharmaceuticals Ltd. Stock?
As of the end of day on the Jul 10, 2026, the price of an XTL Biopharmaceuticals Ltd. (XTLB) share was $2.91.

What is the 52-week high and low for XTL Biopharmaceuticals Ltd. Stock?
The 52-week high for XTL Biopharmaceuticals Ltd. Stock is $19.94 and the 52-week low is $2.02.

What is the market capitalization of XTL Biopharmaceuticals Ltd. Stock?
As of the Jul 10, 2026, the market capitalization of XTL Biopharmaceuticals Ltd. is 6.884M.
Click to get the best stock tips daily for free!
ABOUT XTL BIOPHARMACEUTICALS LTD.
XTL Biopharmaceuticals
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE